A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.
With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID. > read the full study
A research study by the University of Sussex finds that by developing a successful track-record in the field of influenza, GISAID is contributing to global health in at least five ways:
(1) collating the most complete repository of high-quality influenza data in the world; (2) facilitating the rapid sharing of information during outbreaks; (3) supporting the World Health Organization's strain selection process for the seasonal flu vaccine; (4) developing mechanisms to resolve potential conflicts concerning the sharing of virus data; and (5) building greater trust with countries that are key to global pandemic preparedness.
At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.
Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).
During the 6th African Network for the Surveillance of Influenza (ANISE) in Antananarivo, GISAID and isirv - in collaboration with Institut Pasteur de Madagascar and the World Health Organization’s Global Influenza Programme (GIP), with support from United States Agency for International Development (USAID) - are holding a two-day training workshop on genetic sequence analysis of influenza viruses to provide training for monitoring sequence variation among influenza viruses in relation to surveillance of influenza epidemics and detection of resistance to influenza antiviral drugs.
A consortium of investigators, made up of researchers from the University of Cambridge, the University of Wisconsin at Madison, and the Erasmus Medical Center in Rotterdam makes use of data in GISAID to generate synthetic hemagglutinin constructs to produce recombinant H5 viruses and H5-specific ferret antisera, building antigenic maps to represent all H5 viruses that have circulated from 1997 to the present day, providing critical information to stakeholders around the globe, for example for the design of vaccines for humans or poultry.
re3data.org and DataCite, the world’s leading provider of digital object identifiers (DOI) for research data, affirmed the designation of access to GISAID's database and data as Open Access. A persistent link for this designation has been assigned to GISAID for citation purposes (doi:10.17616/R3Q59F).
Directors of WHO Collaborating Centers and Members of GISAID's Scientific Advisory Council consulted with the Global Influenza Program, National Influenza Centers and ERLs, as well as industry representatives on the progress of timely virus data sharing through GISAID, followed by round-table discussions.
Register here to join and connect with thousands of researchers around the globe that made GISAID their primary resource for influenza data
The GISAID Initiative involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform and EpiFlu™ database, Singapore and the United States of America.
15 December 2017 Influenza (Avian and other zoonotic)
26 October 2017 Human infection with avian influenza A(H7N9) virus – China
13 September 2017 Human infection with avian influenza A(H7N9) virus – China